• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

patents

The headquarters of the US Federal Trade Commission FTC in Washington DC November 18 2024
Pharma

Teva moves to delist 200-plus patents from FDA registry: FTC

Teva has asked the FDA to remove hundreds of patents from its registry, according to the FTC.
Eric Sagonowsky Dec 10, 2025 4:58pm
The Capitol Building in Washington DC with bright blue sky - stock photo Becky WrightGetty Images

Senate unanimously passes bill targeting 'patent thickets'

Jul 12, 2024 9:28am
Patents on file

Teva notches loss in inhaler patent case against Amneal

Jun 12, 2024 9:35am
Filing cabinet documents

Activist shareholders press top companies on access to meds

Dec 18, 2023 12:28pm
Federal Trade Commission

AbbVie, Boehringer and more face FTC ire for 'improper' patents

Nov 7, 2023 2:22pm
Ozempic

Viatris gets US agency to review Novo semaglutide patent

Oct 5, 2023 9:10am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings